Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. (Q53502436)

14 May 2018

title

Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. (English)

1 reference

14 May 2018

adaptive radiation therapy

main subject

0 references

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

1 reference

5

1 reference

14 May 2018

Martin Hutchings

object named as

Martin Hutchings

1

0 references

author name string

Annika Loft

2

1 reference

14 May 2018

Mads Hansen

3

1 reference

14 May 2018

Anne Kiil Berthelsen

4

1 reference

14 May 2018

publication date

23 January 2007

1 reference

14 May 2018

European Journal of Haematology

published in

1 reference

14 May 2018

volume

78

1 reference

14 May 2018

issue

3

1 reference

14 May 2018

page(s)

206-212

1 reference

14 May 2018

Breast cancer and other second neoplasms after childhood Hodgkin's disease

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Positron emission tomography for the staging of Hodgkin's lymphoma--increasing the body of evidence in favor of the method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose c

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2006.00802.X

10.1111/J.1600-0609.2006.00802.X

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018